Monkeypox (Mpox) re-emergence: prevalence, diagnostics, countermeasures, and its global effect

While the world is still trying to emerge from the crisis due to the COVID-19 pandemic, and all the nations are trying to nullify the repercussions caused by it; another outbreak known as the monkeypox virus (MPXV) has recommenced. Human monkeypox, a rare viral zoonosis (an infectious disease that...

Full description

Bibliographic Details
Main Authors: Mohammad Amir, Ian Osoro, Amit Sharma, Ranjeet Kumar
Format: Article
Language:English
Published: University of Tabriz 2023-02-01
Series:Journal of Zoonotic Diseases
Subjects:
Online Access:https://jzd.tabrizu.ac.ir/article_16032.html
_version_ 1797810867885047808
author Mohammad Amir
Ian Osoro
Amit Sharma
Ranjeet Kumar
author_facet Mohammad Amir
Ian Osoro
Amit Sharma
Ranjeet Kumar
author_sort Mohammad Amir
collection DOAJ
description While the world is still trying to emerge from the crisis due to the COVID-19 pandemic, and all the nations are trying to nullify the repercussions caused by it; another outbreak known as the monkeypox virus (MPXV) has recommenced. Human monkeypox, a rare viral zoonosis (an infectious disease that can be transferred from non-human animals to humans), is caused by the MPXV, a member of the genus Orthopoxvirus (family Poxviridae, subfamily Chordopoxvirinae). Since eradicating smallpox globally in 1977, monkeypox has been the primary orthopoxvirus infection in humans. On July 14, 2022, the first case in India was reported in the Kollam district of Kerala. It manifests with the same symptoms as smallpox, including flu-like symptoms, fever, malaise, headache, back pain, and a characteristic rash. New medications have shown promising results, but more study is needed for the drug’s efficacy in endemic settings. The monkeypox virus is a high-danger pathogen that causes a significant disease for public health. Consequently, there is a pressing need to develop surveillance capabilities that can yield valuable data for creating suitable preventative, preparedness, and response operations.
first_indexed 2024-03-13T07:14:10Z
format Article
id doaj.art-af8b774640a342cc9b7c8e0da584168b
institution Directory Open Access Journal
issn 2717-2910
language English
last_indexed 2024-03-13T07:14:10Z
publishDate 2023-02-01
publisher University of Tabriz
record_format Article
series Journal of Zoonotic Diseases
spelling doaj.art-af8b774640a342cc9b7c8e0da584168b2023-06-05T11:06:45ZengUniversity of TabrizJournal of Zoonotic Diseases2717-29102023-02-017119920610.22034/JZD.2023.16032Monkeypox (Mpox) re-emergence: prevalence, diagnostics, countermeasures, and its global effectMohammad Amir0Ian Osoro1Amit Sharma2Ranjeet Kumar3Department of Pharmacy Practice, ISF College of Pharmacy, Moga, Punjab, IndiaDepartment of Pharmacy Practice, ISF College of Pharmacy, Moga, Punjab, IndiaDepartment of Pharmacy Practice, ISF College of Pharmacy, Moga, Punjab, IndiaDepartment of Pharmacy Practice, ISF College of Pharmacy, Moga, Punjab, IndiaWhile the world is still trying to emerge from the crisis due to the COVID-19 pandemic, and all the nations are trying to nullify the repercussions caused by it; another outbreak known as the monkeypox virus (MPXV) has recommenced. Human monkeypox, a rare viral zoonosis (an infectious disease that can be transferred from non-human animals to humans), is caused by the MPXV, a member of the genus Orthopoxvirus (family Poxviridae, subfamily Chordopoxvirinae). Since eradicating smallpox globally in 1977, monkeypox has been the primary orthopoxvirus infection in humans. On July 14, 2022, the first case in India was reported in the Kollam district of Kerala. It manifests with the same symptoms as smallpox, including flu-like symptoms, fever, malaise, headache, back pain, and a characteristic rash. New medications have shown promising results, but more study is needed for the drug’s efficacy in endemic settings. The monkeypox virus is a high-danger pathogen that causes a significant disease for public health. Consequently, there is a pressing need to develop surveillance capabilities that can yield valuable data for creating suitable preventative, preparedness, and response operations.https://jzd.tabrizu.ac.ir/article_16032.htmlmonkeypoxsmallpoxbioweapon
spellingShingle Mohammad Amir
Ian Osoro
Amit Sharma
Ranjeet Kumar
Monkeypox (Mpox) re-emergence: prevalence, diagnostics, countermeasures, and its global effect
Journal of Zoonotic Diseases
monkeypox
smallpox
bioweapon
title Monkeypox (Mpox) re-emergence: prevalence, diagnostics, countermeasures, and its global effect
title_full Monkeypox (Mpox) re-emergence: prevalence, diagnostics, countermeasures, and its global effect
title_fullStr Monkeypox (Mpox) re-emergence: prevalence, diagnostics, countermeasures, and its global effect
title_full_unstemmed Monkeypox (Mpox) re-emergence: prevalence, diagnostics, countermeasures, and its global effect
title_short Monkeypox (Mpox) re-emergence: prevalence, diagnostics, countermeasures, and its global effect
title_sort monkeypox mpox re emergence prevalence diagnostics countermeasures and its global effect
topic monkeypox
smallpox
bioweapon
url https://jzd.tabrizu.ac.ir/article_16032.html
work_keys_str_mv AT mohammadamir monkeypoxmpoxreemergenceprevalencediagnosticscountermeasuresanditsglobaleffect
AT ianosoro monkeypoxmpoxreemergenceprevalencediagnosticscountermeasuresanditsglobaleffect
AT amitsharma monkeypoxmpoxreemergenceprevalencediagnosticscountermeasuresanditsglobaleffect
AT ranjeetkumar monkeypoxmpoxreemergenceprevalencediagnosticscountermeasuresanditsglobaleffect